Mostrar el registro sencillo del ítem
dc.contributor.author | Legaz, Isabel | |
dc.contributor.author | Muro, Manuel | |
dc.date.accessioned | 2025-05-06T10:36:43Z | |
dc.date.available | 2025-05-06T10:36:43Z | |
dc.date.issued | 2023 | |
dc.identifier.citation | Legaz I, Muro M. Natural Killer Cells and Their Implications in Immune Response Diversification in Clinical Pathology and Neoplastic Processes. Int J Mol Sci. 24 de abril de 2023;24(9):7743. | |
dc.identifier.issn | 1422-0067 | |
dc.identifier.uri | https://sms.carm.es/ricsmur/handle/123456789/18737 | |
dc.description.abstract | Numerous studies have examined the function of human immune system biomarkers regarding susceptibility, and prognostic, therapeutic, and predictive factors, in various solid and liquid tumors [...]. | |
dc.language.iso | eng | |
dc.publisher | Multidisciplinary Digital Publishing Institute (MDPI) | |
dc.rights | Atribución-NoComercial-SinDerivadas 4.0 España | |
dc.rights.uri | https://creativecommons.org/licenses/by-nc-nd/4.0/deed.es | * |
dc.subject.mesh | Humans | |
dc.subject.mesh | Neoplasms/pathology | |
dc.subject.mesh | Killer Cells, Natural | |
dc.subject.mesh | Immunity | |
dc.subject.mesh | Neoplastic Processes | |
dc.subject.mesh | Biomarkers | |
dc.subject.mesh | Pathology, Clinical | |
dc.title | Natural Killer Cells and Their Implications in Immune Response Diversification in Clinical Pathology and Neoplastic Processes | |
dc.type | info:eu-repo/semantics/article | |
dc.identifier.pmid | 37175450 | |
dc.relation.publisherversion | https://dx.doi.org/10.3390/ijms24097743 | |
dc.type.version | info:eu-repo/semantics/publishedVersion | |
dc.identifier.doi | 10.3390/ijms24097743 | |
dc.journal.title | International Journal of Molecular Sciences |